KCNN4 Antibody Cat. No.: 18-422
KCNN4 Antibody
Specifications
HOST SPECIES: Rabbit
SPECIES REACTIVITY: Human
Recombinant fusion protein containing a sequence corresponding to amino acids 288-427 IMMUNOGEN: of human KCNN4 (NP_002241.1).
TESTED APPLICATIONS: WB
APPLICATIONS: WB: ,1:500 - 1:2000
POSITIVE CONTROL: 1) 293T
PREDICTED MOLECULAR Observed: 53kDa WEIGHT:
Properties
PURIFICATION: Affinity purification
CLONALITY: Polyclonal
ISOTYPE: IgG
CONJUGATE: Unconjugated
PHYSICAL STATE: Liquid
September 26, 2021 1 https://www.prosci-inc.com/kcnn4-antibody-18-422.html BUFFER: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
STORAGE CONDITIONS: Store at -20˚C. Avoid freeze / thaw cycles.
Additional Info
OFFICIAL SYMBOL: KCNN4
DHS2, IK, IK1, IKCA1, KCA4, KCa3.1, SK4, hIKCa1, hKCa4, hSK4, intermediate conductance calcium-activated potassium channel protein 4, SKCa 4, SKCa4, potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4, ALTERNATE NAMES: potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4, putative Gardos channel, putative erythrocyte intermediate conductance calcium-activated potassium Gardos channel, small conductance calcium-activated potassium channel 4
GENE ID: 3783
USER NOTE: Optimal dilutions for each application to be determined by the researcher.
Background and References
The protein encoded by this gene is part of a potentially heterotetrameric voltage- independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization, which promotes calcium influx. The encoded BACKGROUND: protein may be part of the predominant calcium-activated potassium channel in T- lymphocytes. This gene is similar to other KCNN family potassium channel genes, but it differs enough to possibly be considered as part of a new subfamily.
ANTIBODIES FOR RESEARCH USE ONLY.
For additional information, visit ProSci's Terms & Conditions Page.
September 26, 2021 2 https://www.prosci-inc.com/kcnn4-antibody-18-422.html